6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8 Puritas ≥98.0% (HPLC) Favipiravir Intermediate COVID-19 Featured Image

6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8 Puritas ≥98.0% (HPLC) Favipiravir COVID-19

Description:

Nomen chemicum: 6-Fluoro-3-Hydroxypyrazinum-2-Carbonitrile

6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile

CAS: 356783-31-8

Aspectus: Pallida Yellow ad Off-Pulvis alba

Puritas: ≥98.0% (HPLC)

Intermedia Favipiravir (CAS: 259793-96-9) in curatione Influentiae virus et COVID-19

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer cum High puritate et stabulo Quality
Commercial Supple Favipiravir et intermedia:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonatum Hydrochloridum CAS 13433-00-6
3,6-Dichloropyrazinum-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS, 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Chemical Properties:

Nomen chemicum	6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile
Synonyma	6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile
CAS Number	356783-31-8
CATTUS Number	RF-API294
Stock Status	In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae	C5H2FN3O
M. Pondus	139.09
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Pallidus ad Off-White pulveris
Lepidium sativum	IR, HPLC
Humor (KF)	≤1.0%
Residere in Ignition	≤0.50%
una immunditia	≤1.0%
Totalis immunditias	≤2.0%
Metalla gravis	≤20ppm
Puritas	≥98.0% (per HPLC)
Test Standard	Enterprise Standard
Consuetudinem	Medium Favipiravir (CAS 259793-96-9);Antiviral;COVID 19

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile (CAS 356783-31-8) est medius Favipiravir (CAS 259793-96-9).Favipiravir novum medicamentum latum-spectrum antiviralis RNA polymerase dependens (RdRp).Favipiravir in recentibus 1990s primum processit a societate quae postea a firma Fujifilm Iaponica acquisita est ut pars eius transitus e negotio phocatico ad curis.Post probatum contra varias virus virus, medicamentum in Iaponia anno 2014 probatum est ad usus necessarios contra morbos epidemicos vel novos modos influentiae tractandas.In novo coronaviro ingruente, eventus Phase I clinicae studii medicamentorum in mense Martio 2020 edito demonstravit medicamentum habere effectum virium alvi accelerandi ad sublevandum progressum novae coronavirus peripleumoniae.Favipiravir adhiberi potest in curatione aegrorum cum COVID-19 commendata a WHO.Pharmaca moderatoris Generalis Indiae (DCGI) purgata est pro usu "subitis angustiis" inter aegros COVID-19.